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Sharkia GovernorateAbstract Background: Picking up tuberculosis (TB) treatment failure cases and its determinants is
urgently needed in resource-limited developing countries. This work shows incidence and probable
leading factors of TB treatment failure among patients who were managed by a TB control
program.
Aim and objectives: This study aims to promote the TB control program at the ministry of health
and population (MOHP) chest hospitals, Sharkia Governorate with the following objectives: (1)
Determine the incidence of TB treatment failure. (2) Assess probable factors of TB treatment
failure.
Patients and methods: A retrospective cohort study was carried out at MOHP chest hospitals,
Sharkia Governorate. The study sample included all registered TB patients (n=480) during the
study period (2013–2014). There were 30 TB patients (Failed cases) with a positive sputum smear
after 5 months of treatment (Group 1). Cured cases were 384 TB patients whose sputum smear
was positive at the beginning of the treatment but became smear-negative at the end of treatment
and on at least one previous occasion (Group 2). Both groups were compared to evaluate leading
factors of treatment failure.
Results: Of the 480 TB patients registered during the study period (2013–2014), the incidence of
treatment failure was 6.25%. Treatment failure cases were significantly more likely to have: positive
sputum smears at 2 months of TB treatment (p< 0.01), cavities on the baseline chest radiograph
(P< 0.01), extensive disease on the baseline chest radiograph (P< 0.001). Also, retreatment case
(P< 0.01) and CAT 11 treatment category were (p< 0.001).17613.
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in Sharkia Governorate, 2013–2014, Egypt.Conclusion: This study showed that the treatment failure rate in our locality is relatively high.
Positive sputum smear at 2 months of TB treatment, radiological findings and retreatment patients
were found to be predictors of TB treatment failure that should be recognized early and closely
followed up.
 2016 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Tuberculosis (TB) leads to 1.8 million deaths every year. Most
of cases were present in low to middle income countries, this is
further supported by studies carried out in both high and low
income countries which demonstrate significantly higher rates
of TB in their poorer populations [1].
The control of tuberculosis (TB) remains a challenge world-
wide, more so in developing countries like Egypt where treat-
ment target has not yet been met. TB control aims to detect at
least 70% of the sputum smear positive cases and to cure at
least 85% of the sputum smear positive cases. If these goals
are achieved, there is a decrease in prevalence, incidence, trans-
mission and drug resistance to TB [2].
The proportion of pulmonary TB cases whose sputum
smear or cultures are positive after 5 months or later during
the course of treatment is an important point recommended
by the WHO for the monitoring of TB control success [3].
These patients are defined as treatment failure cases. Treat-
ment failure is a serious problem because cases tend to have
higher morbidity and mortality compared with those who
are cured. Also, they carry the risk of being infectious for a
long time; hence, reflects the level of risk to close contacts of
the patients as well as high rates of multidrug-resistant TB
have been found among treatment failure cases especially in
developing countries [4,5].
Few studies have shown that predictors of TB treatment
failure may include social, radiological, laboratory and
treatment-related factors, but these factors can vary in differ-
ent populations and it is important to assess the situation in
specific settings [6].
Aim and objectives
This study aims to promote the TB control program at the
ministry of health and population (MOHP) chest hospitals,
Sharkia Governorate with the following objectives: (1) Deter-
mine the incidence of TB treatment failure. (2) Assess probable
factors of TB treatment failure.
Patients and methods
A retrospective cohort study was carried out at MOHP chest
hospitals, Sharkia Governorate. The study sample included
all registered TB patients (n= 480) during the study period
(2013–2014). There were 30 TB patients (Failed cases) with a
positive sputum smear after 5 months of treatment (Group
1). Cured cases were 384 TB patients whose sputum smear
were positive at the beginning of the treatment but became
smear-negative at the end of treatment and on at least onerawy, D.A. El-Shafei, Evaluation of trea
J. Chest Dis. Tuberc. (2016), http://dx.previous occasion (Group 2). Both groups were compared to
evaluate leading factors of treatment failure.
Data were gathered from TB registry and medical records
from the Sharkia Health Directorate. Identification and review
of the documents and records which evaluate plan/guidelines,
the input processes and output data of studied patients who
were under cover of the MOHP national tuberculosis
control program were revised. The collected data included
TB registration code, patient number in the TB registry, name,
age, sex, residence, history of previous treatment, diagnosis,
culture results, regimen of treatment given, results of sputum
examination (at 0, 2, 3 months, at the end of the initial phase,
and at the end of treatment), and treatment outcome at the end
of treatment. The study included a total number of 480
patients.
Methods
(1) Patients’ history: All patients’ data that were gathered
from records sheets of Sharkia Health Directorate
included:tme
doi. Age and sex.
 Residence (rural or urban).
 Education level (illiterate, primary, secondary, ter-
tiary and university level).
 Marital status (married, single, widowed or
divorced).
 Occupations (employed or unemployed).
 Special habits {smoking (cigarette or goza), alcohol
and drug abuse}.
 Human immune deficiency (HIV) positive cases.
 History of medical co-morbidity {diabetes mellitus
(DM), hypertension (HPN), ischemic heart disease
(IHD), liver diseases, and chronic obstructive pul-
monary diseases (COPD)}.
 History of contact to tuberculous cases.
 History of previous anti-tuberculous treatment:
– Number of treatment courses.
– Regularity in the treatment (regular and irregular)
and if the patient continues treatment or
defaulted.
 Type of treatment (CAT1 or CAT2):nt failur
org/10.1– CAT1 (regimen1) (for all new cases with sputum
smear positive): Treatment regimens have an ini-
tial (or intensive) phase lasting 2 months and a
continuation phase usually lasting 4 or 6 months.
Initial phase, consists of Isoniazid, Rifampicin,
Pyrazinamide and Ethambutol or Streptomycin.
Continuation phase consisting of isoniazide and
rifampicin.e outcome and its predictors among pulmonary tuberculosis patients
016/j.ejcdt.2015.11.002
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in Sharkia– CAT2 (regimen2) (for patients with previous anti-
tuberculos treatment or treatment after interrup-
tion): Treatment regimen consists of 5 drugs in
the initial phase (2 months) and 3 drugs in the
continuation phase (4–6 months). Three of the
drugs isoniazide, rifampicin and ethambutol are
given throughout the treatment [7].(2) Medical data: All recorded data of general and local
examinations that were done for all patients at the time
of admission.
(3) Plain Chest X-ray (CXR) and CT chest: Plain CXR was
done monthly for all patients at the time of admission
and end of treatment (target point). Pathological find-
ings depending on radiology (plain CXR and CT):
Extensive disease, infiltration, cavitation, miliary lesion,
consolidation, collapse, fibrosis, effusion, hydropneu-
mothorax, pneumothorax and lymph node.
(4) Laboratory investigations:
1. Routine laboratory investigations including: Complete
Blood Count (CBC), Erythrocyte Sedimentation Rate
(ESR), serum creatinine and blood urea, ALT and
AST, random blood glucose level. They were done
at admission, monthly and at end of treatment besides
at any time the patient developed new symptoms or
signs.
2. Sputum Ziehl–Neelsen stain studies: The reagents used
are Ziehl–Neelsen carbolfuchsin, acid alcohol and
methylene blue. Acid-fast bacilli will appear bright
red after staining. It was done monthly for all patients
[8].
3. Sputum culture on Lowenstein–Jensen (L.J.) medium:
Lowenstein–Jensen (LJ) Medium is used for the isola-
tion and cultivation ofMycobacteria as bases for selec-
tive, differential and enriched media for Mycobacteria.
It was repeated monthly for all patients [9].
4. Screening of T.B drug susceptibility testing (DST).
 The drugs used for susceptibility testing should not
include those additionally used for treatment.
They must be taken from pure compounds that
are available only from the manufacture.
 For DST, the identical method is used where at
least two sputum specimens should be submitted
to the laboratory for AFB microscopy (smear)
and culture. One of the two cultures can then be
used for DST.Definitions
Patient with positive sputum smears for acid-fast bacilli after
5 months of continuous category I treatment had treatment
failure. A patient with initial treatment success after TB ther-
apy of sufficient length (9 months for severe disease, 6 months
for all others) that developed recurrent TB had treatment
relapse. Treatment default was defined as interruption of treat-
ment for P2 consecutive months. Treatment success was
defined as treatment completion or cure. Retreatment patients
were those receiving their first retreatment regimen after
relapse, failure, or default.this article in press as: M. El-Shabrawy, D.A. El-Shafei, Evaluation of trea
Governorate, 2013–2014, Egypt. J. Chest Dis. Tuberc. (2016), http://dx.Data management
Collected data were computerized and statistically analyzed
using SPSS program (Statistical Package for Social Science)
version 20.0. Qualitative data were represented as frequencies
and percentages. Chi-square test (X2) was carried out for com-
paring the qualitative data and the Fisher’s exact test was used
for an expected cell value frequency less than five. Quantitative
data were compared using student’s t-test. The test results were
considered significant when p-value < 0.05. Logistic regres-
sion analysis was carried out to identify significant predictors
for TB treatment failure.
Results
During the two-year period (2013–2014), there were 480 pul-
monary tuberculosis (TB) cases notified in MOHP chest hospi-
tals where these data were obtained from the Sharkia Health
Directorate. There were 290 (60.4%) males and 190 (39.6%)
females with a mean age of 35.7 ± 11.3 years. Most of the
patients (40.0%) were within the age group 25–34 years. Only
24 patients (5.0%) were above 65 years. The majority of
patients were married (54.2%) and living in rural areas
(70.8%). They had average educational level (secondary school
and above) (50.0%), with an overall rate of unemployment
(58.3%) (Table 1).
Most of those patients were newly diagnosed pulmonary
TB (n= 425; 88.5%) cases. About 62.5% of patients were
known smokers, there were no HIV positive cases and about
36.4% of patients had medical comorbidities where diabetes
mellitus was the most common disease (45.7%) (Table 1).
Treatment outcomes of all patients were overall 384 (80%)
of the notified patients were cured: 30 defaulted patients
(6.25%), 27 dead cases (5.6%), 30 patients had treatment fail-
ure (6.25%) and 9 cases were transferred out or missed (1.9%)
(Graph 1).
The high percentage of the studied treatment failure
patients were distributed at Abu Hamad (13.30%), Zagazig
and Belbais (12.0%) as illustrated in Graph 2.
Baseline characteristics of treatment failure cases were sig-
nificantly more likely to be old age (p< 0.001), male gender
(p< 0 .01), rural residence (p< 0.001) lower educational level
(p< 0.001) and unemployment (p< 0.0001) (Table 2).
By clinical data, treatment failure cases were significantly
more likely to have positive sputum smears at 2 months of
TB treatment (p< 0.01) cavities on the baseline chest radio-
graph (p< 0.01), extensive disease on the baseline chest radio-
graph (p< 0.001). Also, retreatment (p< 0 .01) and CAT 11
treatment category are (p< 0.001) as shown in (Table 3).
On Simple logistic regression analysis (Table 4); it was
found that the most important predictors of TB treatment
failure among patients in the Sharkia Governorate were posi-
tive sputum smear at 2nd month (O.R = 10.19), illiteracy
(O.R = 106.45), rural residence (O.R = 80.01), radiology
(O.R = 3.47), and retreatment cases (O.R = 1.06).
Discussion
The global goal of the World Health Organization (WHO) TB
strategy is to achieve 2015 universal targets for decreasing thetment failure outcome and its predictors among pulmonary tuberculosis patients
doi.org/10.1016/j.ejcdt.2015.11.002
Table 1 Base line characteristics of the studied patients.
Characteristic No. (n= 480) Percent (%)
Age group
15–24 48 10.0
25–34 192 40.0
35–44 168 35.0
45–64 48 10.0
> 65 24 5.0
Age (years)
Mean + SD 35.7 ± 11.3
Sex
Male 290 60.4
Female 190 39.6
Residence
Rural 340 70.8
Urban 140 29.2
Education
Illiterate 168 35.0
Primary 72 15.0
Secondary 96 20.0
University 144 30.0
Marital status
Married 260 54.2
Single 200 41.7
Other (widowed, divorced) 20 4.1
Occupation
Employed 200 41.7
Unemployed 280 58.3
Habits
Cigarette smoking 190 39.6
Goza smoking 110 22.9
Alcohol use 25 5.2
Drug abuse 70 14.6
Type of patient
New case 425 88.5
Retreatment case 55 11.5
HIV +ve cases 0 0.0
Medical comorbidities
DM 80 16.7
HPN 25 5.2
IHD 30 6.3
Liver diseases 25 5.2
COPD 15 3.1
Total 175 36.5
Graph 1 The outcome of the studied cases.
4 M. El-Shabrawy, D.A. El-Shafeiburden of disease caused by TB. These targets are that inci-
dence should be falling and that prevalence and incidence rates
should be halved by 2015 in comparison to 1990 levels [8].
In this study, more than half of patients were males (60.4%)
while females were 39.6% with a mean age 35.7 ± 11.3 years
(Table 1). This in consistence with the epidemiology of tuber-
culosis, as males are more exposed to infection in the commu-
nity than females. Also, the occupational and mental stress or
social factors which may prevent females from seeking medical
advice, resulting in inaccurate lowering of the incidence rate
[8]. The mean age (35.7 ± 11.3 years) represents the period
of physical, mental, and occupational stress. This was in agree-
ment with those found by Mohamed [9], Kamal [10] andPlease cite this article in press as: M. El-Shabrawy, D.A. El-Shafei, Evaluation of trea
in Sharkia Governorate, 2013–2014, Egypt. J. Chest Dis. Tuberc. (2016), http://dx.Fouad [11] who found near similar age groups. Most patients
were from rural areas (70.8%). Near similar results were found
in other studies conducted in different governorates of Egypt
[12,13].
Poverty, close interaction within the community, as well as
a low level of water supply and sanitation; may all explain the
increased TB cases in rural areas. Drinking or handling con-
taminated milk and agricultural workers may acquire the dis-
ease when in close physical contact with potentially infected
animals may also be other factors [14].
Regarding the occupation, there were 280 unemployed
patients (58.3%) and 200 employed cases (41.7%) (Table 1).
Near similar results were reported by Floyd et al. and Lade-
foged et al. who notified that, a several-fold increase in the
incidence of tuberculosis was noted among the unemployed
compared to the employed among cases from different coun-
tries with varying degrees of TB disease [15].
Undoubtedly poverty due to poor diet or stress and greater
difficulties in using health services contributes to the incidence
of tuberculosis disease. Also, unemployment leads to behavior
that increases the risk of tuberculosis, such as addiction or
higher alcohol consumption, economic decline and homeless-
ness [16].
Cigarette smoking was the most frequent special habit of
the studied patients which represented 63.3% of cases. This
is in consistence with Jee, Gajalakshmi and Lam TH who
found that current smokers developed TB and subsequently
died within the follow-up period more than non-smokers
[17,18].
Factors that may contribute to the increased susceptibility
of smokers to develop TB infection may be; Smoking damages
the lungs and impacts the body’s immune system and occur-
rence of TB has been shown to be linked to altered immune
response of immune cells such as macrophages, monocytes
and CD4 lymphocytes. Other mechanisms, such as mechanical
disruption of cilia function and hormonal effects could also
appear secondary to smoking [19].
Diabetes mellitus was by far the most common (45.7%)
comorbidity of the studied patients. In agreement with Mc
Cornick and colleagues who documented the association
between diabetes mellitus and tuberculosis in 5000 TB
patients. Using retrospective data they found that the co mor-
bidity of TB-DM exceeded that of TB-HIV. Patients with TB
and DM were older, more likely to have hemoptysis and pul-
monary cavitation, were smear positive at diagnosis and
remain positive at the end of the first and second month of
treatment [20].tment failure outcome and its predictors among pulmonary tuberculosis patients
doi.org/10.1016/j.ejcdt.2015.11.002
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Graph 2 Geographic distribution of treatment failure patients’ in the Sharkia governorate.
Table 2 Comparison between Group 1 (Failed cases) and Group 2 (Cured cases) regarding demographic characteristics of treatment
failure.
Characteristic Group 1 (N= 30) Group 2 (N= 384) P
Age (years)
Mean ± SD 55.5 ± 8.8 36.9 ± 12.0 0.00**
Sex
Male 20 66.7 235 61.2 0.013*
Female 10 33.3 149 38.8
Residence
Rural 28 93.3 259 67.4 0.00**
Urban 2 125
2 6.7 125 32.6
Education
Illiterate 22 73.3 151 39.3 0.00**
Primary 6 20.0 58 15.1
Secondary 0 0.0 85 22.1
University 2 6.7 90 23.5
Marital status
Single 9 30.0 150 39.0 0.23
Married 19 63.3 225 58.6
Other (widowed, divorced) 2 6.7 9 2.4
Habits
Goza smoking 5 16.7 90 23.4 0.39
Cigarette smoking 15 50.0 155 40.3 0.30
Alcohol use 1 3.33 13 3.38 1.0
Drug abuse 3 7.6 28 6.3 0.72
Occupation
Employed 10 33.3 180 46.9 0.0005**
Unemployed 20 66.7 204 53.1
Medical comorbidities 21 70.0 140 36.5 0.0007**
* Statistically significant.
** Statistically highly significant.
Evaluation of treatment failure outcome in tuberculosis patients 5Treatment outcome among the studied patients revealed
that 384 patients were cured (80%), 27 patients dead (5.6%),
treatment failure patients were 6.25%, defaulter cases were
6.25% and transferred or missed cases constituted 1.9% of
patients (Graph 1). The case detection rate in 2008, in EgyptPlease cite this article in press as: M. El-Shabrawy, D.A. El-Shafei, Evaluation of trea
in Sharkia Governorate, 2013–2014, Egypt. J. Chest Dis. Tuberc. (2016), http://dx.was 78% (global target is 70%) and treatment success rate
was 89% (global target is 85%) [21].
TB treatment failure in Egypt is a serious problem facing
national tuberculosis control programs due to different risk
factors regarding the disease. In Egypt, treatment failuretment failure outcome and its predictors among pulmonary tuberculosis patients
doi.org/10.1016/j.ejcdt.2015.11.002
Table 3 Comparison between Group 1 (Failed cases) and Group 2 (Cured cases) regarding clinical characteristics of treatment failure.
Characteristic Group 1 (N= 30) Group 2 (N= 384) P
CXR findings
Cavity on chest X-ray 19 63.3 0 0.0 0.0**
Extensive disease on CXR 11 36.7 0 0.0 0.00**
Sputum smear conversion to ve after 2 months 14 46.7 284 73.95 0.01*
Weight gain after 2 months of treatment 9 30.0 350 91.1 0.00**
Treatment category
CAT 1 4 13.3 315 82.0 0.00**
CAT 11 26 86.7 69 18.0
Type of patient
New case 23 76.7 344 89.6 0.019*
Retreatment case 7 23.3 40 10.4
* Statistically significant.
** Statistically highly significant.
Table 4 Logistic regression analysis; for significant predictors of TB treatment failure among patients in the Sharkia Governorate
during 2013–2014.
Independent factors B Wald P O.R (95% C.I)
Male gender 0.072 .017 0.896 1.93 (0.52–0.2.74)
Illiteracy 4.668 14.978 0.000** 106.46 (10.01–113.91)
Rural residence 4.633 15.548 0.000** 80.01 (11.00–214.09)
Radiology 1.243 5.962 0.015* 3.47 (1.28–9.41)
+ve sputum smear at 2nd month 1.680 11.019 0.001** 10.19 (5.07–12.50)
DM 0.419 .401 0.527 1.52 (0.42–5.55)
Retreatment 0.062 6.327 0.012* 1.06 (1.01–1.12)
Unemployment 0.379 3.766 0.052 0.68 (0.47–1.00)
B = beta coefficient; O.R = Odds ratio; Wald = chi-square.
* Statistically significant.
** Statistically highly significant.
6 M. El-Shabrawy, D.A. El-Shafeiaccounts for 3–5% of the treatment outcome of new smear
positive cases and 13–17% of re-treated cases [22]. Also, near
similar results were found by Mohamed [10] who reported that
treatment failure patients were 16.1% of his studied patients.
In this study, treatment failure patients were of an older age
than the cured group (Table 2). Old TB patients may be at risk
of increased physical disability resulting in increased delay in
clearing the mycobacterium bacilli probably due to decreasing
immunity. These results were unlike findings from Uganda and
Egypt which showed no differences in age [3,23]
Also, this study showed that the male gender was significant
with the treatment failure group than the cured one (Table 2).
This is consistent with findings from Brazil [24], but unlike
results in Uganda and Egypt. This suggests that male smear-
positive TB patients need to be monitored closely for improved
adherence during TB treatment [3,23].
Other socio-demographic data such as, residence, education
and occupation were found to be associated with TB treatment
failure group more than the cured one (Table 2). This may be
explained by: living further from the TB clinics make patients
not return for drug refills because of the longer distance. Low
educational level and unemployment add further to poor
adherence and loss of interest to complete the treatment
course.
This is in consistence with Hasker et al. who studied socio-
demographic factors including unemployment, education andPlease cite this article in press as: M. El-Shabrawy, D.A. El-Shafei, Evaluation of trea
in Sharkia Governorate, 2013–2014, Egypt. J. Chest Dis. Tuberc. (2016), http://dx.distance to the clinic and published it as medical risk factors
for treatment failure [25].
Unsuccessful sputum smear conversion at the 2nd month of
the TB treatment course, retreatment TB cases and CAT11
regimen were found to be more significant with treatment fail-
ure patients than cured patients (Table 3). This is in agreement
with results of Namukwaya et al. [23] and Chavez Pachas et al.
[26].
After two months of tuberculosis treatment, sputum smear
microscopy is routinely carried out in national TB programs.
Thus, TB control programs consider patients who have smear
positive after two months of tuberculosis treatment to be at-
risk of treatment failure [27].
Our results were in consistence with Dooley et al. [28], who
studied outcomes of retreatment cases with the Category II
regimen which was suboptimal and they found that treatment
failure among those patients was unacceptably high.
Among those more significant associated factors studied in
(Tables 2 and 3), we found that, independent predictors for
treatment failure were; sociodemographic factors; living in
rural and illiteracy (Table 4). This association between treat-
ment failure and rural patients may be due to lower awareness
of TB treatment and the long distance between their residence
and the treatment resources [29].
Illiteracy is usually associated with low socioeconomic sta-
tus that makes personal and family adaptation to treatmenttment failure outcome and its predictors among pulmonary tuberculosis patients
doi.org/10.1016/j.ejcdt.2015.11.002
Evaluation of treatment failure outcome in tuberculosis patients 7more difficult. Also, illiteracy may be the reason patients often
prefer to be treated away from their place of residence. Such
conditions contribute to irregular treatment, which results in
failure [24].
Clinical factors associated with treatment failure were; pos-
itivity of sputum smears at 2nd month of antituberculous
drugs course, retreatment cases and radiology of patient
(Table 4).
Positivity of sputum smear at 2nd month of TB treatment
was found to be associated with treatment failure in this study.
This is in agreement with findings in Peru and Uganda.
Patients found to have persistent smear positivity after two
months of treatment should be investigated further using spu-
tum culture and be treated further based on drug sensitivity
testing [30].
This study also found that, previous treatment for TB was a
predictor of treatment failure (Table 4). Near similar results
were reported by de Albuquerque et al. who found that a
history of prior TB treatment was significantly associated with
unsuccessful treatment outcomes. Similarly, Anunnatsiri et al.
also found that a history of previous TB treatment was associ-
ated with treatment failure and death [24,31].
Prior to TB treatment, association with treatment failure is
a clear indication of the importance of properly completing
treatment and monitoring patients [32].
As regards CXR findings, our study showed that patients
with cavities and advanced lesions will be in favor of treatment
failure outcome (Table 4). This is in consistence with Bao et al.
[33], who found that treatment failure outcome was more
likely among patients with cavitations than those without.
Also, another study by Talay et al. [34] showed that treatment
failure outcome among patients with extensive lesions on chest
X-rays was more than those with non-extensive lesions.
Our study did not find age, male gender and occupation to
be independent risk factors of TB treatment failure and this is
in consistence with Morsy et al. [3], and Namukwaya et al. [23]
but in contrary to studies elsewhere [35].
Clinical factors previously described by other authors as
risk factors for TB treatment failure including diabetes melli-
tus, persistent fever, weight loss and HIV sero-positivity were
not significant in this work [36].
This study had some limitations. Data were retrospectively
collected from TB treatment registers. This study does not
have additional data to confirm or refute the findings. In addi-
tion, there is no information on participants’ knowledge of TB,
TB treatment adherence, quality of education given the patient
and anti-TB drug side effects; these factors may affect TB
treatment outcome.
Conclusion
This study showed that the treatment failure rate in our local-
ity is relatively high. Positive sputum smear at 2nd month of
TB treatment, radiological findings and retreatment patients
were found to be predictors of TB treatment failure that
should be recognized early and closely followed up.
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